Proteolysis-Targeting Chimeras (PROTACs) represent a novel drug design strategy. The principle includes a PROTAC molecule that simultaneously binds a target protein (Protein of Interest, POI) and an E3 ubiquitin ligase, forming a ternary complex.

< 1 >

Messages

If you are interested in our products, please leave your email and we will contact you as soon as possible. Thank you!